tiprankstipranks
Trending News
More News >
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Canadian Market

Cardiol Therapeutics (CRDL) Income Statement

Compare
221 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q3 2025), Cardiol Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Cardiol Therapeutics's net income was C$-9.96M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 78.76KC$ 0.00
Gross Profit
C$ -373.11KC$ -248.35KC$ -219.91KC$ 78.76KC$ -229.54K
Operating Expenses
C$ 39.90MC$ 29.54MC$ 41.34MC$ 38.74MC$ 20.69M
Depreciation and Amortization
C$ 373.11KC$ 248.35KC$ 219.91KC$ 220.42KC$ 229.54K
EBITDA
C$ -36.30MC$ -27.88MC$ -30.71MC$ -38.44MC$ -20.41M
Operating Income
C$ -40.28MC$ -29.79MC$ -50.34MC$ -45.47MC$ -20.61M
Other Income/Expenses
C$ 3.60MC$ 1.66MC$ 10.41MC$ 7.03MC$ 49.53K
Pretax Income
C$ -36.68MC$ -28.13MC$ -30.93MC$ -31.64MC$ -20.64M
Net Income
C$ -36.68MC$ -28.13MC$ -11.52MC$ -24.72MC$ -20.65M
Per Share Metrics
Basic EPS
C$ -0.51C$ -0.44C$ -0.18C$ -0.57C$ -0.69
Diluted EPS
C$ -0.51C$ -0.44C$ -0.18C$ -0.57C$ -0.69
Weighted Average Shares Outstanding
71.57M 64.46M 62.51M 43.22M 29.86M
Weighted Average Shares Outstanding (Diluted)
71.57M 64.46M 62.51M 43.22M 29.86M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History